These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12470524)

  • 1. Impact of urinary FSH price: a cost-effectiveness analysis of recombinant and urinary FSH in assisted reproduction techniques in the USA.
    Silverberg K; Schertz J; Falk B; Beresniak A
    Reprod Biomed Online; 2002; 5(3):265-9. PubMed ID: 12470524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK.
    Daya S; Ledger W; Auray JP; Duru G; Silverberg K; Wikland M; Bouzayen R; Howles CM; Beresniak A
    Hum Reprod; 2001 Dec; 16(12):2563-9. PubMed ID: 11726575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of recombinant versus urinary follicle-stimulating hormone in assisted reproduction techniques in the Spanish public health care system.
    Romeu A; Balasch J; Ruiz Balda JA; Barri PN; Daya S; Auray JP; Duru G; Beresniak A; Peinado JA
    J Assist Reprod Genet; 2003 Aug; 20(8):294-300. PubMed ID: 12948090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Evaluation of Three Frequently Used Gonadotrophins in Assisted Reproduction Techniques in the Management of Infertility in the Netherlands.
    Fragoulakis V; Pescott CP; Smeenk JM; van Santbrink EJ; Oosterhuis GJ; Broekmans FJ; Maniadakis N
    Appl Health Econ Health Policy; 2016 Dec; 14(6):719-727. PubMed ID: 27581117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reflections on the cost-effectiveness of recombinant FSH in assisted reproduction. The clinician's perspective.
    Balasch J; Barri PN
    J Assist Reprod Genet; 2001 Feb; 18(2):45-55. PubMed ID: 11285980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States.
    Silverberg K; Daya S; Auray JP; Duru G; Ledger W; Wikland M; Bouzayen R; O'Brien M; Falk B; Beresniak A
    Fertil Steril; 2002 Jan; 77(1):107-13. PubMed ID: 11779599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
    Daya S; Gunby J
    Cochrane Database Syst Rev; 2000; (4):CD002810. PubMed ID: 11034767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WITHDRAWN: Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
    Daya S; Gunby J
    Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD002810. PubMed ID: 17636708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovulation induction with urinary FSH or recombinant FSH in polycystic ovary syndrome patients: a prospective randomized analysis of cost-effectiveness.
    Gerli S; Casini ML; Unfer V; Costabile L; Mignosa M; Di Renzo GC
    Reprod Biomed Online; 2004 Nov; 9(5):494-9. PubMed ID: 15588465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data.
    Hatoum HT; Keye WR; Marrs RP; Walton SM; Marshall DC
    Fertil Steril; 2005 Mar; 83(3):804-7. PubMed ID: 15749525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin treatments.
    Sykes D; Out HJ; Palmer SJ; van Loon J
    Hum Reprod; 2001 Dec; 16(12):2557-62. PubMed ID: 11726574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction.
    Daya S
    Fertil Steril; 2002 Apr; 77(4):711-4. PubMed ID: 11937121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacoeconomic advantages of recombinant FSH vs urinary derived FSH].
    Beresniak A
    Gynecol Obstet Fertil; 2004 Sep; 32(9):756-9. PubMed ID: 15380758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro fertilization in France: economic aspects and influence of the gonadotropin choice (urinary vs. recombinant) on cost].
    de Mouzon J; Allavena E; Schmitt C; Frappé M
    Gynecol Obstet Fertil; 2004 Jun; 32(6):508-18. PubMed ID: 15217566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness.
    Gerli S; Casini ML; Unfer V; Costabile L; Bini V; Di Renzo GC
    Fertil Steril; 2004 Sep; 82(3):573-8. PubMed ID: 15374698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with recombinant follicle-stimulating hormone (FSH) and urinary FSH: a retrospective case- controlled analysis.
    Ravhon A; Lavery S; Aurell R; Trew G; Margara R; Winston R
    Fertil Steril; 2001 May; 75(5):920-5. PubMed ID: 11334903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis.
    Revelli A; Poso F; Gennarelli G; Moffa F; Grassi G; Massobrio M
    Reprod Biol Endocrinol; 2006 Jul; 4():38. PubMed ID: 16848893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction.
    Daya S; Gunby J
    Hum Reprod; 1999 Sep; 14(9):2207-15. PubMed ID: 10469682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Bayram N; van Wely M; van Der Veen F
    Cochrane Database Syst Rev; 2001; (2):CD002121. PubMed ID: 11406034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.